SCHEMBL24309570

SCHEMBL24309570

CC(=O)Nc1cccc(SNc2nc(Oc3ccccc3Cl)cc(-c3c(C)cccc3C)n2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESRRA P11474 2/20 0.41
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ JAK2 O60674 2/20 0.37
▸ LMNA P02545 5/20 0.37
▸ POLB P06746 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ MAPT P10636 3/20 0.36
▸ TP53 P04637 1/20 0.36
▸ AURKA O14965 1/20 0.36
▸ AURKB Q96GD4 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ P2RX4 Q99571 1/20 0.35
▸ ABL1 P00519 1/20 0.35
▸ PDGFRB P09619 1/20 0.35
▸ SRC P12931 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29566384 0.82 MAPT (0.49) ESRRAMEN1KMT2AALDH1A1LMNA
SCHEMBL26807039 0.82 MAPT (0.49) ESRRAMEN1KMT2AALDH1A1LMNA
SCHEMBL24309662 0.79 RORC (0.35) SMN1; SMN2RAB9ARORC
SCHEMBL24310532 0.77 NR1H2 (0.35) LMNASRC
SCHEMBL24309252 0.74 RXRA (0.39) MEN1KMT2AALDH1A1JAK2LMNA
SCHEMBL24309770 0.73 LMNA (0.34) MEN1KMT2AALDH1A1LMNAPOLB
SCHEMBL24330885 0.73 TDP1 (0.34) LMNAPOLBMAPTKDM4ERAB9A
SCHEMBL24310009 0.72 GPR39 (0.45) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL24309263 0.72 POLB (0.34) MEN1KMT2ALMNAPOLBSMN1; SMN2
SCHEMBL24310579 0.72 RORC (0.35) LMNAKDM4ERORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback